Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Y Donath

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Diabetes Technology & Therapeutics|April 24, 2023
Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric BypassAntonio Ferreira, Katja A Schönenberger, Natascha Potoczna, et al.
The American Journal of Clinical Nutrition|May 5, 2024
Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023Mehmet Furkan Burak, Takara L Stanley, Elizabeth A Lawson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2007
The Fas pathway is involved in pancreatic beta cell secretory functionDesiree M Schumann, Kathrin Maedler, Isobel Franklin, et al.
Scientific Reports|February 22, 2020
Inhibition of IL-1beta improves Glycaemia in a Mouse Model for Gestational DiabetesFriederike Schulze, Josua Wehner, Denise V Kratschmar, et al.
Canadian Journal of Diabetes|July 12, 2025
Blood characteristics of patients with type 2 diabetes and response of their peripheral blood mononuclear cells to inhibitors of the NLRP3-inflammasome and caspase-1Joyce de Paula Souza, Justus S Fischer, Karine Jeanneau, et al.
Frontiers in Immunology|October 16, 2024
TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trialCassandra Bazile, Magdy M Abdel Malik, Courtney Ackeifi, et al.
Immunity|November 23, 2017
Interleukin-33-Activated Islet-Resident Innate Lymphoid Cells Promote Insulin Secretion through Myeloid Cell Retinoic Acid ProductionElise Dalmas, Frank M Lehmann, Erez Dror, et al.
Nature Medicine|November 1, 2011
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cellsHelga Ellingsgaard, Irina Hauselmann, Beat Schuler, et al.
Diabetologia|April 22, 2010
Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat dietJ A Ehses, D T Meier, S Wueest, et al.
Eclinicalmedicine|September 21, 2022
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trialMatthias Hepprich, Jonathan M Mudry, Claudia Gregoriano, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Diabetes Technology & Therapeutics|April 24, 2023
Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric BypassAntonio Ferreira, Katja A Schönenberger, Natascha Potoczna, et al.
The American Journal of Clinical Nutrition|May 5, 2024
Adiposity, immunity, and inflammation: interrelationships in health and disease: a report from 24th Annual Harvard Nutrition Obesity Symposium, June 2023Mehmet Furkan Burak, Takara L Stanley, Elizabeth A Lawson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2007
The Fas pathway is involved in pancreatic beta cell secretory functionDesiree M Schumann, Kathrin Maedler, Isobel Franklin, et al.
Scientific Reports|February 22, 2020
Inhibition of IL-1beta improves Glycaemia in a Mouse Model for Gestational DiabetesFriederike Schulze, Josua Wehner, Denise V Kratschmar, et al.
Canadian Journal of Diabetes|July 12, 2025
Blood characteristics of patients with type 2 diabetes and response of their peripheral blood mononuclear cells to inhibitors of the NLRP3-inflammasome and caspase-1Joyce de Paula Souza, Justus S Fischer, Karine Jeanneau, et al.
Frontiers in Immunology|October 16, 2024
TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trialCassandra Bazile, Magdy M Abdel Malik, Courtney Ackeifi, et al.
Immunity|November 23, 2017
Interleukin-33-Activated Islet-Resident Innate Lymphoid Cells Promote Insulin Secretion through Myeloid Cell Retinoic Acid ProductionElise Dalmas, Frank M Lehmann, Erez Dror, et al.
Nature Medicine|November 1, 2011
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cellsHelga Ellingsgaard, Irina Hauselmann, Beat Schuler, et al.
Diabetologia|April 22, 2010
Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat dietJ A Ehses, D T Meier, S Wueest, et al.
Eclinicalmedicine|September 21, 2022
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trialMatthias Hepprich, Jonathan M Mudry, Claudia Gregoriano, et al.
Pageof 13